Close Menu

long QT syndrome

Nine of the genes analyzed had limited or disputed evidence linking them to long QT syndrome, suggesting they should not be included in genetic testing panels.

Researchers saw clinically actionable heart disease mutations in fewer than 5 percent of sudden infant death syndrome cases interrogated by molecular autopsy.

Researchers find that energy drinks could be dangerous for patients with familial long QT syndrome, according to Live Science.

In PNAS this week: sequencing approaches to characterize cisplatin-mediated DNA damage, somatic mosaicism in long-QT syndrome case, and more.

The study, focused on two genes associated with cardiac disorders, found that patient phenotypes did not correlate with the presence or absence of a pathogenic variant.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.

NEW YORK (GenomeWeb) – A recently launched lawsuit in Canada challenging the practice of patenting genomic DNA is also asking the Federal Court to determine that advanced diagnostics utilizing next-generation sequencing platforms do not infringe patents on older testing methods involving the ampl

This article has been updated with the name of the US laboratory that sent Ontario's Ministry of Health a cease and desist letter.
NEW YORK (GenomeWeb) – The Children's Hospital of Eastern Ontario is challenging the legality of US gene patents in Canada.

NEW YORK (GenomeWeb News) – InformedDNA today said that it is providing genetic counseling to certain members of health plan Cigna.

ChanTest will develop non-clinical assays, databases, and computational models for assessing the risk of serious cardiac events associated with drug-induced QT prolongation.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.